Europe wants to use the vaccination turbo – but cannot because there is too little vaccine. That should change now.
The EU wants to tighten the reins on exports and manufacturers’ deliveries to Europe. Means: Export stop for manufacturers who do not meet their vaccine deliveries to the EU.
Who this concerns: especially AstraZeneca.
Literally said EU leader Ursula von der Leyen At a press conference Wednesday noon: We “have to ensure two things when exporting: reciprocity and proportionality. I would like to be very clear here: If this situation does not change, we will think about making exports to vaccine-producing countries dependent on the degree of their own openness. “
And then: “And we will also think about whether exports to countries that have higher vaccination rates than we do are proportionate.”
According to von der Leyens, AstraZeneca will be in the second quarter according to current information only about 70 million cans deliver. “That is considerably less than the 180 million that they have contractually agreed to deliver.” At AstraZeneca there is still “plenty of room for improvement”.
What will happen to the vaccination ban in Germany?
Vaccination with AstraZeneca was stopped on Monday by Federal Health Minister Jens Spahn (CDU). The European Medicines Agency (EMA) should decide on Thursday how to proceed. And there is great hope that AstraZeneca will be given the green light again.
Make sure Europe gets its fair share
Ursula von der Leyen also made it clear: “This is a question of fairness. We are ready to use all the tools we need to achieve that. It’s about making sure Europe gets its fair share. We will invest even more in Europe’s capacities beyond this acute phase. In order to ensure the long-term supply of the EU, we will rely on closer cooperation with trustworthy companies. And these are also the messages I have for the heads of state and government at the next European Council. “
Von der Leyen is sticking to the goal of 70 percent of adults in the EU to be fully vaccinated by the end of the summer. The start of the vaccination campaign was difficult. But progress has been made. Biontech / Pfizer and Moderna kept their supply contracts.
“Now we have to concentrate on the time until summer”, said von der Leyen. The vaccine shipments would increase. So far, four vaccines have been approved in the EU.
According to von der Leyen, 200 million cans from Biontech / Pfizer and 35 million from Moderna will come from April to June.
In the course of April the vaccine also came from Johnson & Johnson which is expected to have about 55 million cans in the second quarter. Unlike the other vaccines, this preparation only needs to be administered once. If Astrazeneca keeps its promises for the first quarter, 100 million cans would be delivered by all manufacturers by the end of March, said von der Leyen.